Aspirin inhibits Chlamydia pneumoniae-induced NF-κB activation, cyclo-oxygenase-2 expression and prostaglandin E2 synthesis and attenuates chlamydial growth

Journal of Medical Microbiology

Volumn 52, Issue 5, 2003, Pages 409-415

  Yoneda, Hiroshi ^a   Miura, Koshiro ^a,b   Matsushima, Hiroshi ^a   Sugi, Kazuro ^b   Murakami, Tomoyuki ^b   Ouchi, Kazunobu ^c,d   Yamashita, Katsuhiro ^a,e   Itoh, Haruhide ^a,f   Nakazawa, Teruko ^a   Suzuki, Michiyasu ^a   Shirai, Mutsunori ^a  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NATIONAL SANYO HOSPITAL   (Japan)

^c Saiseikai Shimonoseki General Hospital   (Japan)

^d KAWASAKI MEDICAL SCHOOL   (Japan)

^e YAMAGUCHI ROSAI HOSPITAL   (Japan)

^f Kanmon Medical Center   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CYCLOOXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDOMETACIN; NITRATE; NITRIC OXIDE; NITRITE; PROSTAGLANDIN E2; TRYPTOPHAN;

ANTIBACTERIAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTERIAL GROWTH; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOFLUORESCENCE TEST; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; RADIOIMMUNOASSAY; REPORTER GENE;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CHLAMYDOPHILA PNEUMONIAE; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION, BACTERIAL; GENES, REPORTER; HUMANS; INDOMETHACIN; ISOENZYMES; MEMBRANE PROTEINS; NF-KAPPA B; NITRIC OXIDE; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; TRYPTOPHAN; TUMOR CELLS, CULTURED;

EID: 0037718616     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.04992-0     Document Type: Article

References (52)

1. Appleby, S. B., Ristimaki, A., Neilson, K., Narko, K. & Hla, T. (1994). Structure of the human cyclo-oxygenase-2 gene. Biochem J 302, 723-727.
2. Baeuerle, P. A. & Baltimore, D. (1988). IκB: a specific inhibitor of the NF-κB transcription factor. Science 242, 540-546.
3. Baeuerle, P. A. & Henkel, T. (1994). Function and activation of NF-κB in the immune system. Annu Rev Immunol 12, 141-179.
4. Brand, K., Page, S., Rogler, G. & 7 other authors (1996). Activated transcription factor nuclear factor-κB is present in the atherosclerotic lesion. J Clin Invest 97, 1715-1722.
5. Budker, V., Gurevich, V., Hagstrom, J. E., Bortzov, F. & Wolff, J. A. (1996). pH-sensitive, cationic liposomes: a new synthetic virus-like vector. Nat Biotechnol 14, 760-764.
6. Caldwell, H. D., Kromhout, J. & Schachter, J. (1981). Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis. Infect Immun 31, 1161-1176.
7. Chu, S. C., Marks-Konczalik, J., Wu, H. P., Banks, T. C. & Moss, J. (1998). Analysis of the cytokine-stimulated human inducible nitric oxide synthase (iNOS) gene: characterization of differences between human and mouse iNOS promoters. Biochem Biophys Res Commun 248, 871-878.
8. Collins, T. (1993). Endothelial nuclear factor-κB and initiation of the atherosclerotic lesion. Lab Invest 68, 499-508.
9. Cook, P. J., Honeybourne, D., Lip, G. Y., Beevers, D. G., Wise, R. & Davies, P. (1998). Chlamydia pneumoniae antibody titers are significantly associated with acute stroke and transient cerebral ischemia. Stroke 29, 404-410.
10. Cybulsky, M. I. & Gimbrone, M. A., Jr (1991). Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science 251, 788-791.
11. D'Acquisto, F., Iuvone, T., Rombola, L., Sautebin, L., Di Rosa, M. & Carnuccio, R. (1997). Involvement of NF-κB in the regulation of cyclooxygenase-2 protein expression in LPS-stimulated J774 macrophages. FEBS Lett 418, 175-178.
12. Dechend, R., Maass, M., Gieffers, J., Dietz, R., Scheidereit, C., Leutz, A. & Gulba, D. C. (1999). Chlamydia pneumoniae infection of vascular smooth muscle and endothelial cells activates NF-κB and induces tissue factor and PAI-1 expression: a potential link to accelerated arteriosclerosis. Circulation 100, 1369-1373.
13. Dichtl, W., Nilsson, L., Goncalves, I., Ares, M. P., Banfi, C., Calara, F., Hamsten, A., Eriksson, P. & Nilsson, J. (1999). Very low-density lipoprotein activates nuclear factor-κB in endothelial cells. Circ Res 84, 1085-1094.
14. Gawaz, M., Neumann, F. J., Dickfeld, T. & 8 other authors (1998). Activated platelets induce monocyte chemotactic protein-1 secretion and surface expression of intercellular adhesion molecule-1 on endothelial cells. Circulation 98, 1164-1171.
15. Gierse, J. K., Koboldt, C. M., Walker, M. C., Seibert, K. & Isakson, P. C. (1999). Kinetic basis for selective inhibition of cyclo-oxygenases. Biochem J 339, 607-614.
16. Goodwin, J. S., Bankhurst, A. D. & Messner, R. P. (1977). Suppression of human T-cell mitogenesis by prostaglandin. Existence of a prostaglandin-producing suppressor cell. J Exp Med 146, 1719-1734.
17. Grayston, J. T. (1992). Infections caused by Chlamydia pneumoniae strain TWAR. Clin Infect Dis 15, 757-761.
18. Grayston, J. T., Kuo, C. C., Wang, S. P. & Altman, J. (1986). A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections. N Engl J Med 315, 161-168.
19. Grayston, J. T., Campbell, L. A., Kuo, C. C., Mordhorst, C. H., Saikku, P., Thom, D. H. & Wang, S. P. (1990). A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR. J Infect Dis 161, 618-625.
20. Gupta, S., Barrett, T., Whitmarsh, A. J., Cavanagh, J., Sluss, H. K., Derijard, B. & Davis, R. J. (1996). Selective interaction of JNK protein kinase isoforms with transcription factors. EMBO J 15, 2760-2770.
21. + T cells secreting low amounts of both IL-2 and IL-4. J Immunol 163, 6173-6179.
22. Jackson, L. A., Campbell, L. A., Kuo, C. C., Rodriguez, D. I., Lee, A. & Grayston, J. T. (1997). Isolation of Chlamydia pneumoniae from a carotid endarterectomy specimen. J Infect Dis 176, 292-295.
23. Kol, A., Bourcier, T., Lichtman, A. H. & Libby, P. (1999). Chlamydial and human heat shock protein 60s activate human vascular endothelium, smooth muscle cells, and macrophages. J Clin Invest 103, 571-577.
24. Kopp, E. & Ghosh, S. (1994). Inhibition of NF-κB by sodium salicylate and aspirin. Science 265, 956-959.
25. Krull, M., Klucken, A. C., Wuppermann, F. N. & 7 other authors (1999). Signal transduction pathways activated in endothelial cells following infection with Chlamydia pneumoniae. J Immunol 162, 4834-4841.
26. Kuo, C. C., Shor, A., Campbell, L. A., Fukushi, H., Patton, D. L. & Grayston, J. T. (1993). Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J Infect Dis 167, 841-849.
27. Marks-Konczalik, J., Chu, S. C. & Moss, J. (1998). Cytokine-mediated transcriptional induction of the human inducible nitric oxide synthase gene requires both activator protein 1 and nuclear factor κB-binding sites. J Biol Chem 273, 22201-22208.
28. Matsushima, H., Shirai, M., Ouchi, K., Yamashita, K., Kakutani, T., Furukawa, S. & Nakazawa, T. (1999). Lymphotoxin inhibits Chlamydia pneumoniae growth in HEp-2 cells. Infect Immun 67, 3175-3179.
29. Melnick, S. L., Shahar, E., Folsom, A. R., Grayston, J. T., Sorlie, P. D., Wang, S. P. & Szklo, M. (1993). Past infection by Chlamydia pneumoniae strain TWAR and asymptomatic carotid atherosclerosis. Am J Med 95, 499-504.
30. Miyashita, N., Toyota, E., Sawayama, T. & Matsushima, T. (1998). An association of an antibody against Chlamydia pneumoniae and coronary heart disease observed in Japan. Eur Heart J 19, 971.
31. Molestina, R. E., Miller, R. D., Lentsch, A. B., Ramirez, J. A. & Summersgill, J. T. (2000). Requirement for NF-κB in transcriptional activation of monocyte chemotactic protein 1 by Chlamydia pneumoniae in human endothelial cells. Infect Immun 68, 4282-4288.
32. Neish, A. S., Williams, A. J., Palmer, H. J., Whitley, M. Z. & Collins, T. (1992). Functional analysis of the human vascular cell adhesion molecule 1 promoter. J Exp Med 176, 1583-1593.
33. Ouchi, K., Fujii, B., Kanamoto, Y., Karita, M., Shirai, M. & Nakazawa, T. (1998). Chlamydia pneumoniae in coronary and iliac arteries of Japanese patients with atherosclerotic cardiovascular diseases. J Med Microbiol 47, 907-913.
34. Pantoja, L. G., Miller, R. D., Ramirez, J. A., Molestina, R. E. & Summersgill, J. T. (2000). Inhibition of Chlamydia pneumoniae replication in human aortic smooth muscle cells by gamma interferon-induced indoleamine 2,3-dioxygenase activity. Infect Immun 68, 6478-6481.
35. Pantoja, L. G., Miller, R. D., Ramirez, J. A., Molestina, R. E. & Summersgill, J. T. (2001). Characterization of Chlamydia pneumoniae persistence in HEp-2 cells treated with gamma interferon. Infect Immun 69, 7927-7932.
36. Pistritto, G., Franzese, O., Pozzoli, G., Mancuso, C., Tringali, G., Preziosi, P. & Navarra, P. (1999). Bacterial lipopolysaccharide increases prostaglandin production by rat astrocytes via inducible cyclo-oxygenase: evidence for the involvement of nuclear factor κB. Biochem Biophys Res Commun 263, 570-574.
37. Poston, R. N., Haskard, D. O., Coucher, J. R., Gall, N. P. & Johnson-Tidey, R. R. (1992). Expression of intercellular adhesion molecule-1 in atherosclerotic plaques. Am J Pathol 140, 665-673.
38. Ramirez, J. A. (1996). Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis. Ann Intern Med 125, 979-982.
39. Ross, R. (1993). The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362, 801-809.
40. Saikku, P., Leinonen, M., Mattila, K., Ekman, M. R., Nieminen, M. S., Makela, P. H., Huttunen, J. K. & Valtonen, V. (1988). Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet ii, 983-986.
41. Shaper, N. L., Hardiun-Lepers, A. & Shaper, J. H. (1994). Male germ cell expression of murine β4-galactosyltransferase. A 796-base pair genomic region, containing two cAMP-responsive element (CRE)-like elements, mediates male germ cell-specific expression in transgenic mice. J Biol Chem 269, 25165-25171.
42. Sharma, S. A., Tummuru, M. K. R., Blaser, M. J. & Kerr, L. D. (1998). Activation of IL-8 gene expression by Helicobacter pylori is regulated by transcription factor nuclear factor-κB in gastric epithelial cells. J Immunol 160, 2401-2407.
43. Shirai, M., Hirakawa, H., Kimoto, M. & 8 other authors (2000). Comparison of whole genome sequences of Chlamydia pneumoniae J138 from Japan and CWL029 from USA. Nucleic Acids Res 28, 2311-2314.
44. Shor, A., Kuo, C. C. & Patton, D. L. (1992). Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaques. S Afr Med J 82, 158-161.
45. Siebenlist, U., Franzoso, G. & Brown, K. (1994). Structure, regulation and function of NF-κB. Annu Rev Cell Biol 10, 405-455.
46. Song, Y. G., Kwon, H. M., Kim, J. M. & 10 other authors (2000). Serologic and histopathologic study of Chlamydia pneumoniae infection in atherosclerosis: a possible pathogenetic mechanism of atherosclerosis induced by Chlamydia pneumoniae. Yonsei Med J 41, 319-327.
47. Speir, E., Yu, Z. X., Ferrans, V. J., Huang, E. S. & Epstein, S. E. (1998). Aspirin attenuates cytomegalovirus infectivity and gene expression mediated by cyclooxygenase-2 in coronary artery smooth muscle cells. Circ Res 83, 210-216.
48. Tiran, A., Gruber, H. J., Graier, W. F., Wagner, A. H., van Leeuwen, E. B. M. & Tiran, B. (2002). Aspirin inhibits Chlamydia pneumoniae-induced nuclear factor-κB activation, cytokine expression, and bacterial development in human endothelial cells. Arterioscler Thromb Vasc Biol 22, 1075-1080.
49. Traenckner, E. B., Wilk, S. & Baeuerle, P. A. (1994). A proteasome inhibitor prevents activation of NF-κB and stabilizes a newly phosphorylated form of IκB-α that is still bound to NF-κB. EMBO J 13, 5433-5441.
50. Wimmer, M. L. J., Sandmann-Strupp, R., Saikku, P. & Haberl, R. L. (1996). Association of chlamydial infection with cerebrovascular disease. Stroke 27, 2207-2210.
51. Yamashita, K., Ouchi, K., Shirai, M., Gondo, T., Nakazawa, T. & Ito, H. (1998). Distribution of Chlamydia pneumoniae infection in the atherosclerotic carotid artery. Stroke 29, 773-778.
52. Yin, M. J., Yamamoto, Y. & Gaynor, R. B. (1998). The anti-inflammatory agents aspirin and salicylate inhibit the activity of IκB kinase-β. Nature 396, 77-80.